None listed
Conditions
Interventions
Dietary Supplement : Subjects take placebo or EFR twice a day for 8 weeks
Sponsors
Bundang Jesaeng Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subject who voluntarily agrees to participate and signs in informed consent form 2) Healthy people, 20 = age < 70. 3) Stress self assessment scaled above "strong" 4) Subjects suffered from upper respiratory track infection or cold-related symptoms which have possibilities to cause upper respiratory track infection more than two times in the past one year. 5) White blood cell(WBC) ranged “normal”
Exclusion criteria
Exclusion criteria: 1) Patients who was diagnosed and are currently in the treatment of diabetes 2) Subjects who are currently in the treatment of significant clinical disease related to acute or chronic cardiovascular system, immune system, respiratory system, liver biliary, kidney and urinary tract, nervous system, musculoskeletal disorders, psychic, infection and blood neoplastic. 3) Subjects who have medical history with myocardial infarction or cerebrovascular disease within 6 months. 4) Subjects who have a neurologically or psychologically important medial history or who is currently suffering from a disease. 5) Subjects who have uncontrolled high blood pressure. 6) Subjects whose AST or ALT exceeds 3 times of normal range. 7) Subjects whose creatinine exceeds 2 times of normal range. 8) Subjects who have complained of severe gastrointestinal symptoms such as heartburn, indigestion. 9) Subjects who got a vaccination within 1 months before screening. 10) Excessive smoker 11) Subjects who usually consume alcohol as follows - men: 210g/week, women 140g/week 12) Subjects whose BMI is under 18.5 or exceeds 30.0 13) Subjects who continue to consume beta-glucan or rice bran-containing food within one month of their first visit 14) Subjects who have intaken or is intaking functional foods 15) Subjects who are planning to participate other studies within one month of their first visit 16) Subjects who are pregnant or breastfeeding or planning a pregnancy. 17) Subjects who are sensitive to test foods/algae or have food allergies. 18) Subjects who are deemed to be inappropriate to this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NK cell activity (%) et al. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events et al. | — |
Countries
Korea, Republic of
Contacts
Public Contactkim hae
Bundang Jesaeng Hospital
Outcome results
None listed